yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34051477-B0D43B46-0495-4724-858A-D7532C85D319
Q34051477-B0D43B46-0495-4724-858A-D7532C85D319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34051477-B0D43B46-0495-4724-858A-D7532C85D319
Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.
P2860
Q34051477-B0D43B46-0495-4724-858A-D7532C85D319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34051477-B0D43B46-0495-4724-858A-D7532C85D319
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a44272aa5e348125e17c42c7688f60b404c72a45
P2860
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome